CytImmune nails down $1M for gold nanoparticle chemo treatment; Coagulated blood element produces drug delivery vehicle

> CytImmune has raised $1 million to fuel further clinical development of an experimental cancer treatment using gold nanoparticles to deliver chemotherapy drugs to tumors, MedCity News reports. Story

> Scientists have developed nanosized drug delivery vehicles made from fibrin, a natural biopolymer produced when blood coagulates, Nature India reports. Story (sub. req.)

> Burlington, MA-based Neuron Systems has gained the right to evaluate pSivida's ($PSDV) bioerodible Durasert drug delivery technology for back-of-the-eye diseases. Release

> Hospira ($HSP) gained FDA approval for its Symbiq 3.13 infusion pump, which is designed to deliver drugs through wireless communication and have better safeguards against medication errors. Release

And Finally... Xigo Nanotools, a nanoparticle device company, has raised further investment toward manufacturing a device designed to re-engineer the active particle ingredients in a drug to give it the same benefit at a lower concentration. Story